{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:09:07Z","timestamp":1790028547085,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["SCR_022381"],"award-info":[{"award-number":["SCR_022381"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["P30CA013696"],"award-info":[{"award-number":["P30CA013696"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016842","name":"Institut Fran\u00e7ais de Bioinformatique","doi-asserted-by":"publisher","award":["ANR-11-INBS-0013"],"award-info":[{"award-number":["ANR-11-INBS-0013"]}],"id":[{"id":"10.13039\/100016842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031313","name":"Herbert Irving Comprehensive Cancer Center, Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018109","name":"Veterans Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM134910"],"award-info":[{"award-number":["R35 GM134910"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["SCR_005012"],"award-info":[{"award-number":["SCR_005012"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101312","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T02:14:17Z","timestamp":1759630457000},"page":"101312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-6780","authenticated-orcid":false,"given":"Maryam","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Basseville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-901X","authenticated-orcid":false,"given":"Thomas","family":"Litman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7682-0797","authenticated-orcid":false,"given":"Lubov","family":"Petrukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Remotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana V.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Damoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikanth","family":"Maddipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-3650","authenticated-orcid":false,"given":"Robert W.","family":"Robey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6708-0330","authenticated-orcid":false,"given":"Susan E.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101312_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molcel.2012.04.009","article-title":"R loops: from transcription byproducts to threats to genome stability","volume":"46","author":"Aguilera","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101312_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.drup.2025.101312_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2012.5","article-title":"Breathless cancer cells get fat on glutamine","volume":"22","author":"Anastasiou","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2025.101312_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112643","article-title":"A histone deacetylase inhibitor induces Acetyl-CoA depletion leading to lethal metabolic stress in RAS-Pathway activated cells","volume":"14","author":"Basseville","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2025.101312_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.2009.07954.x","article-title":"Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma","volume":"148","author":"Bates","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101312_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/bjh.13400","article-title":"Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data","volume":"170","author":"Bates","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101312_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101312_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8935-6-27","article-title":"Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression","volume":"6","author":"Bhaskara","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.drup.2025.101312_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101312_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.9","article-title":"HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses","volume":"4","author":"Bolden","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101312_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101312_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.trecan.2021.04.006","article-title":"Hypertranscription and replication stress in cancer","volume":"7","author":"Bowry","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2025.101312_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424286122","article-title":"eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer","volume":"122","author":"Boyer","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.drup.2025.101312_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101312_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101312_bib16","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-019-13086-5","article-title":"eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma","volume":"10","author":"Chan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101312_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101312_bib18","unstructured":"Daniel Romo, O.R., Zhu, Mingzhao, Kenneth, G., Hull, 2021. Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia.WO 2017173313 A1. International Patent Application. 2017-10-05."},{"key":"10.1016\/j.drup.2025.101312_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101312_bib20","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.15252\/embj.201796438","article-title":"MYC and tumor metabolism: chicken and egg","volume":"36","author":"Dejure","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2025.101312_bib21","doi-asserted-by":"crossref","first-page":"eabd6927","DOI":"10.1126\/sciadv.abd6927","article-title":"Relaxed initiation pausing of ribosomes drives oncogenic translation","volume":"7","author":"Dong","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101312_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235926","article-title":"Epigenetics in pancreatic ductal adenocarcinoma: impact on biology and utilization in diagnostics and treatment","volume":"14","author":"Elrakaybi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2025.101312_bib23","article-title":"Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model","author":"English","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.drup.2025.101312_bib24","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","article-title":"Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor 4A RNA helicase","volume":"63","author":"Ernst","year":"2020","journal-title":"J. Med Chem."},{"key":"10.1016\/j.drup.2025.101312_bib25","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","article-title":"Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor-4A RNA helicase","volume":"63","author":"Ernst","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2025.101312_bib26","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1200\/JCO.2017.35.15_suppl.2579","article-title":"A phase 1 dose escalation study of eFT508, an inhibitor of mitogen-activated protein kinase-interacting serine\/threonine kinase-1 (MNK-1) and MNK-2 in patients with advanced solid tumors","volume":"35","author":"Falchook","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101312_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","article-title":"Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.drup.2025.101312_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12964-020-00607-9","article-title":"Eukaryotic translation initiation factors as promising targets in cancer therapy","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.drup.2025.101312_bib29","first-page":"37","article-title":"Romidepsin in the treatment of cutaneous T-cell lymphoma","volume":"2","author":"Jain","year":"2011","journal-title":"J. Blood Med."},{"key":"10.1016\/j.drup.2025.101312_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/OP.22.00328","article-title":"Pancreatic adenocarcinoma management","volume":"19","author":"Jiang","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.drup.2025.101312_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1139\/bcb-2019-0307","article-title":"Investigation of the mechanism of action of a potent pateamine a analog, des-methyl, des-amino pateamine A (DMDAPatA)","volume":"98","author":"Kommaraju","year":"2020","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.drup.2025.101312_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13087","article-title":"Increased global transcription activity as a mechanism of replication stress in cancer","volume":"7","author":"Kotsantis","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101312_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3748\/wjg.v19.i8.1173","article-title":"Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?","volume":"19","author":"Koutsounas","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drup.2025.101312_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(75)90107-5","article-title":"Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells","volume":"5","author":"Leder","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101312_bib35","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2025.101312_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101312_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.149","article-title":"Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor","volume":"3","author":"Lindqvist","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101312_bib38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40257-018-0380-7","article-title":"Current status of HDAC inhibitors in cutaneous T-cell lymphoma","volume":"19","author":"Lopez","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.drup.2025.101312_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molcel.2005.10.008","article-title":"Inhibition of eukaryotic translation initiation by the marine natural product pateamine A","volume":"20","author":"Low","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101312_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.molonc.2014.05.001","article-title":"Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin","volume":"8","author":"Luchenko","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.drup.2025.101312_bib41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.molonc.2014.05.001","article-title":"Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin","volume":"8","author":"Luchenko","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.drup.2025.101312_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin Oncol."},{"key":"10.1016\/j.drup.2025.101312_bib43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1158\/2159-8290.CD-20-1826","article-title":"MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma","volume":"12","author":"Maddipati","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101312_bib44","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","article-title":"eIF4E \u2013 from translation to transformation","volume":"23","author":"Mamane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101312_bib45","article-title":"Identification of MYC synthetic lethal genes and networks","author":"Martin","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.drup.2025.101312_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat. Genet"},{"key":"10.1016\/j.drup.2025.101312_bib47","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.4161\/cc.6648","article-title":"Control of nucleotide biosynthesis by the MYC oncoprotein","volume":"7","author":"McMahon","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.drup.2025.101312_bib48","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.2022.40.16_suppl.3081","article-title":"First-in-human phase 1\/2 dose escalation and expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with solid tumors","author":"Meric-Bernstam","year":"2022","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.drup.2025.101312_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.chembiol.2020.12.006","article-title":"Functional mimicry revealed by the crystal structure of an eIF4A:RNA complex bound to the interfacial inhibitor, desmethyl pateamine A","volume":"28","author":"Naineni","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.drup.2025.101312_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167651","article-title":"Cotargeting a MYC\/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer","volume":"133","author":"Nardi","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2025.101312_bib51","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1111\/febs.13746","article-title":"How do tumor cells respond to HDAC inhibition?","volume":"283","author":"Newbold","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2025.101312_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101312_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-6527-4_8","article-title":"DNA fiber spreading assay to test HDACi effects on DNA and its replication","volume":"1510","author":"Nikolova","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drup.2025.101312_bib54","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41375-021-01308-z","article-title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML","volume":"35","author":"Nishida","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101312_bib55","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.34974","article-title":"Recent histone deacetylase inhibitors in cancer therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2025.101312_bib56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","article-title":"Targeting the eIF4F translation initiation complex: a critical nexus for cancer development","volume":"75","author":"Pelletier","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101312_bib57","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4161\/epi.6.10.17200","article-title":"Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells","volume":"6","author":"P\u00e9rez-Perarnau","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.drup.2025.101312_bib58","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101312_bib59","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","article-title":"Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma","volume":"117","author":"Piekarz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101312_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114055","article-title":"The MNK1\/2-eIF4E axis as a potential therapeutic target in melanoma","volume":"21","author":"Prabhu","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101312_bib61","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1042\/BST20150163","article-title":"Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence","volume":"43","author":"Raza","year":"2015","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.drup.2025.101312_bib62","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101312_bib63","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/268462a0","article-title":"n-Butyrate causes histone modification in HeLa and friend erythroleukaemia cells","volume":"268","author":"Riggs","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101312_bib64","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","article-title":"Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity","volume":"89","author":"Robey","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101312_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vascn.2010.11.003","article-title":"Rapid detection of ABC transporter interaction: potential utility in pharmacology","volume":"63","author":"Robey","year":"2011","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.drup.2025.101312_bib66","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/1541-7786.MCR-20-0833","article-title":"R-Loop\u2013Mediated ssDNA breaks accumulate following short-term exposure to the HDAC inhibitor romidepsin","volume":"19","author":"Safari","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.drup.2025.101312_bib67","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41596-019-0159-1","article-title":"High-resolution, strand-specific R-loop mapping via S9. 6-Based DNA\u2013RNA immunoprecipitation and high-throughput sequencing","volume":"14","author":"Sanz","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.drup.2025.101312_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/modpathol.3880547","article-title":"c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance","volume":"15","author":"Schleger","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2025.101312_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2015.09.012","article-title":"The fanconi anemia pathway maintains genome stability by coordinating replication and transcription","volume":"60","author":"Schwab","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101312_bib70","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/10428194.2017.1295143","article-title":"Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials","volume":"58","author":"Shustov","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drup.2025.101312_bib71","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/0008-5472.CAN-20-2929","article-title":"Targeting eIF4A-dependent translation of KRAS signaling molecules","volume":"81","author":"Singh","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101312_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.molcel.2014.10.020","article-title":"Transcription-coupled nucleotide excision repair factors promote R-Loop-Induced genome instability","volume":"56","author":"Sollier","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101312_bib73","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.trecan.2021.01.008","article-title":"Drivers of gene expression dysregulation in pancreatic cancer","volume":"7","author":"Venkat","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2025.101312_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101312_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-021-00500-y","article-title":"Alternative approaches to target myc for cancer treatment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101312_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081082","article-title":"Epigenetic alterations in pancreatic cancer metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.drup.2025.101312_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068915","article-title":"Inhibition of histone deacetylase 3 causes replication stress in cutaneous t cell lymphoma","volume":"8","author":"Wells","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2025.101312_bib78","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.105.083956","article-title":"Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines","volume":"314","author":"Xiao","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drup.2025.101312_bib79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.104.072033","article-title":"Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1","volume":"313","author":"Xiao","year":"2005","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.drup.2025.101312_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn0238","article-title":"Widespread hypertranscription in aggressive human cancers","volume":"8","author":"Zatzman","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101312_bib81","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12935-021-02390-0","article-title":"Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC\/miR-9 signaling","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:34:00Z","timestamp":1773185640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":81,"alternative-id":["S1368764625001153"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101312","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101312"}}